RESUMEN
Venous thromboembolism (VTE) is a common clinical problem that is associated with substantial morbidity and mortality. The aim of this study was to describe the clinical practices in VTE prophylaxis in university and peripheral hospitals in Morocco. This is a national, cross-sectional, multicenter, observational study assessing the management of the VTE risk in selected Moroccan hospitals (four university and three peripheral). The thromboembolic risk of the selected patients was assessed according to the American College of Chest Physicians (ACCP) guidelines (2008). We hypothesized that interventions for VTE guideline implementation in those hospitals may improve prophylaxis use for hospitalized patients. A total of 1318 patients were analyzed: 467 (35.5%) medical and 851 (64.5%) surgical. The mean age of patients was 52.6 ± 16.5 years, and 52.7% were female. A total of 51.1% patients were considered to be at risk of VTE according to ACCP guidelines and were eligible for thromboprophylaxis (TP). Medical patients were more likely to present risk factors than surgical patients (53.6 vs. 50.7%, respectively). TP was prescribed for 53.1% of these patients, 57.4% in at-risk surgical patients and 50.3% in at-risk medical patients. TP was also prescribed for 42.9% of non-at-risk patients. The concordance between the recommended and the prescribed prophylaxis was poor for the total population (kappa = 0.110). TP did not improve sufficiently in our hospitals, even after implementation of the guidelines. New strategies are required to appropriately address TP in hospitalized patients.
Asunto(s)
Premedicación/métodos , Tromboembolia Venosa/prevención & control , Adulto , Anciano , Estudios Transversales , Femenino , Adhesión a Directriz , Hospitales , Humanos , Masculino , Persona de Mediana Edad , Marruecos , Medición de Riesgo , Resultado del TratamientoRESUMEN
Behçet disease is a multi-systemic complex vasculitis with unknown etiology characterized by different clinical involvements, including mucocutaneous, ocular, vascular, articular, neurological and gastrointestinal manifestations. Growing evidence supports that different phenotypes, characterized by clusters of co-existing involvements, can be distinguished. Namely, the vascular phenotype identifies a specific group of patients who suffer from recurrent inflammatory thrombosis and arterial involvement. Vascular disease develops in up to 40% with a definite male preponderance and is usually an early manifestation. It is one of the main causes of death in Behçet's disease. Venous involvement is significantly more common than arterial disease and lower extremity deep vein thrombosis is its most frequent manifestation. Arterial disease involves mostly pulmonary arteries and aorta and manifests mainly in the form of aneurysms. Glucocorticoids and immunosuppressant's are the recommended first-line treatments in vasculo-Behçet. Furthermore, randomized controlled trials are still needed to assess the role of adding anticoagulation to current standard therapy in venous thrombosis in Behçet's disease and to assess the role of anti-TNF alpha therapy in vasculo-Behçet.
Asunto(s)
Aneurisma , Síndrome de Behçet , Trombosis , Trombosis de la Vena , Masculino , Humanos , Síndrome de Behçet/complicaciones , Síndrome de Behçet/diagnóstico , Síndrome de Behçet/tratamiento farmacológico , Inhibidores del Factor de Necrosis Tumoral/uso terapéutico , Aneurisma/complicaciones , Trombosis/complicaciones , Trombosis de la Vena/etiología , Trombosis de la Vena/complicaciones , Arteria PulmonarAsunto(s)
Anemia Perniciosa/diagnóstico , Demencia/diagnóstico , Enfermedades del Sistema Nervioso/diagnóstico , Convulsiones/diagnóstico , Enfermedades de la Médula Espinal/diagnóstico , Deficiencia de Vitamina B 12/diagnóstico , Anemia Perniciosa/complicaciones , Anemia Perniciosa/diagnóstico por imagen , Demencia/complicaciones , Demencia/diagnóstico por imagen , Diagnóstico Diferencial , Femenino , Humanos , Imagen por Resonancia Magnética , Persona de Mediana Edad , Enfermedades del Sistema Nervioso/diagnóstico por imagen , Enfermedades del Sistema Nervioso/etiología , Trastornos Psicóticos/diagnóstico , Trastornos Psicóticos/diagnóstico por imagen , Trastornos Psicóticos/etiología , Convulsiones/diagnóstico por imagen , Convulsiones/etiología , Enfermedades de la Médula Espinal/complicaciones , Enfermedades de la Médula Espinal/diagnóstico por imagen , Deficiencia de Vitamina B 12/complicaciones , Deficiencia de Vitamina B 12/diagnóstico por imagenAsunto(s)
Infecciones Oportunistas Relacionadas con el SIDA/complicaciones , Colitis/complicaciones , Infecciones por Citomegalovirus/complicaciones , Infecciones por VIH/complicaciones , Encefalopatía de Wernicke/etiología , Infecciones Oportunistas Relacionadas con el SIDA/patología , Colitis/patología , Colitis/virología , Infecciones por Citomegalovirus/patología , Resultado Fatal , Infecciones por VIH/patología , VIH-1 , Humanos , Masculino , Persona de Mediana Edad , Deficiencia de Tiamina/complicaciones , Deficiencia de Tiamina/patología , Encefalopatía de Wernicke/patología , Encefalopatía de Wernicke/virologíaRESUMEN
Salmonella osteoarticular infections involve mainly long bones such as the femur, tibia, and humerus in patients with sickle cell disease (SCD). We report here two unusual cases of Salmonella osteoarthritis affecting sacroiliac and sternoclavicular joints in two patients with SCD, one patient also being followed for rheumatoid arthritis. Because of misleading presentation, diagnosis of septic osteoarthritis in patients with SCD requires a high index of suspicion and an early treatment.
Asunto(s)
Anemia de Células Falciformes/complicaciones , Artritis Infecciosa/microbiología , Articulación Sacroiliaca/microbiología , Infecciones por Salmonella/patología , Articulación Esternoclavicular/microbiología , Adulto , Anemia de Células Falciformes/microbiología , Artritis Infecciosa/tratamiento farmacológico , Población Negra , Femenino , Humanos , MasculinoRESUMEN
INTRODUCTION: Cutaneous tuberculosis is rare in the developed countries. We report a case of tuberculous gumma in an immunocompetent patient diagnosed late. CASE-REPORT: A 33-year-old Moroccan woman was diagnosed with tuberculous gumma after presenting cutaneous nodules and subcutaneous abscesses that had developed during pregnancy and were present for 11 months. Cutaneous and pulmonary tuberculosis was discovered. The patient recovered under antimycobacterial treatment. COMMENTS: Cutaneous tuberculosis presents with a wide spectrum of clinical lesions. It should be considered in the presence of poorly known lesions such as gumma, which require investigation for underlying tuberculosis.
Asunto(s)
Absceso/diagnóstico , Tuberculosis Cutánea/diagnóstico , Adulto , Femenino , Francia , Humanos , Tuberculosis Cutánea/complicaciones , Tuberculosis Pulmonar/complicacionesRESUMEN
BACKGROUND: Hyperhomocysteinemia has been suspected of favoring thrombosis. Several case-control studies and even a meta-analysis have confirmed a link between venous thrombosis and hyperhomocysteinemia. Homocysteine is due to genetic and acquired factors (poor diet in folate and vitamin B12, older age, renal impairment, thyroid diseases, and malignancies) induced by the intake and the concentrations of vitamin B9 or B12 in the majority of cases. CASES PRESENTATION: We report the cases of four Moroccan patients who presented with acute vein thrombosis of different sites: a 34-year-old man, a 60-year-old man, a 58-year-old man, and a 47-year-old woman. All patients had a low level of cobalamin with marked hyperhomocysteinemia with normal serum and red cell folic acid. Venous thrombosis revealed pernicious anemia in all patients. Their low levels of cobalamin, atrophic gastritis, and positive results for gastric parietal cell antibodies confirmed the diagnosis of pernicious anemia. There was no evidence of immobilization, recent surgery, malignancy, antiphospholipid antibody, myeloproliferative disorder, or hormone replacement therapy. No deficiencies in protein C and protein S were detected; they had normal antithrombin III function and factor V Leiden; no prothrombin gene mutations were detected. Treatment included orally administered anticoagulation therapy and cobalamin supplementation. The outcome was favorable in all cases. CONCLUSIONS: These reports demonstrate that pernicious anemia, on its own, can lead to hyperhomocysteinemia that is significant enough to lead to thrombosis. Understanding the molecular pathogenesis of the development of thrombosis in patients with hyperhomocysteinemia related to Biermer disease would help us to identify patients at risk and to treat them accordingly. The literature concerning the relationship between homocysteine and venous thrombosis is briefly reviewed.
Asunto(s)
Anemia Perniciosa , Anticoagulantes/administración & dosificación , Células Parietales Gástricas/inmunología , Tromboembolia Venosa , Vitamina B 12 , Adulto , Anemia Perniciosa/sangre , Anemia Perniciosa/complicaciones , Anemia Perniciosa/diagnóstico , Anemia Perniciosa/terapia , Anticuerpos/sangre , Femenino , Ácido Fólico/sangre , Humanos , Hiperhomocisteinemia/diagnóstico , Hiperhomocisteinemia/etiología , Hiperhomocisteinemia/metabolismo , Hiperhomocisteinemia/terapia , Masculino , Persona de Mediana Edad , Resultado del Tratamiento , Tromboembolia Venosa/diagnóstico , Tromboembolia Venosa/etiología , Tromboembolia Venosa/metabolismo , Tromboembolia Venosa/terapia , Vitamina B 12/administración & dosificación , Vitamina B 12/sangre , Deficiencia de Vitamina B 12/diagnóstico , Deficiencia de Vitamina B 12/etiología , Vitaminas/administración & dosificaciónRESUMEN
PURPOSE: Neurological symptoms of B12 vitamin deficiency are polymorph. Causes are dominated by Biermer's disease and B12 vitamin non dissociation that is frequent in the elderly. METHODS: We realized a retrospective study during 11 years. Patients with neurological symptoms associated to megaloblastosis were included. Treatment with B12 vitamin lead to haematological manifestation regression. RESULTS: 26 cases were analyzed. Mean age was 50+/-14.5 years and there were 11 women and 15 men. Neurological signs included combined medullar sclerosis (N = 10), peripheral neuropathy (N = 10), isolated paresthesia (N = 5) and inferior limb pyramidal syndrome (N = 1). Neurological signs revealed vitamin B12 deficiency in 4 cases. Mean haemoglobin rate was 6.2+/-2.6 g/dl, mean MCV was 109+/-56 fl. Eight patients had macrocytic anaemia, nine bi-cytopenia and eight deep pancytopenia. Electromyography (N = 8) confirmed neuropathy and medullar MRI (N = 2) showed antero-posterior cordonal demyelinisation of cervico-dorsal medulla. Causes of B12 vitamin deficiency were Biermer's disease (N = 11), non dissociation of B12 vitamin's syndrome (N = 8) and partial gastrectomy (N = 1). In 6 patients, no aetiology was found. Treatment with parenteral vitamin B12 induced neurological symptoms regression in 14 cases. Patient with neurological disorder had significantly higher platelet count and haemoglobin level as compared with patients without neurological disorder. Reticulocyte crisis was more precocious in patients with neurological disorders. CONCLUSION: Neurological symptoms in vitamin B12 deficiency are frequent. We insist on isolated forms, inaugural forms and on the interest of medullar MRI for early diagnosis.
Asunto(s)
Enfermedades del Sistema Nervioso/etiología , Deficiencia de Vitamina B 12/complicaciones , Vitamina B 12/uso terapéutico , Complejo Vitamínico B/uso terapéutico , Adulto , Anciano , Anciano de 80 o más Años , Anemia Perniciosa/etiología , Electromiografía , Potenciales Evocados , Femenino , Humanos , Imagen por Resonancia Magnética , Masculino , Persona de Mediana Edad , Enfermedades del Sistema Nervioso/diagnóstico , Enfermedades del Sistema Nervioso/tratamiento farmacológico , Enfermedades del Sistema Nervioso Periférico/etiología , Estudios Retrospectivos , Resultado del Tratamiento , Vitamina B 12/administración & dosificación , Deficiencia de Vitamina B 12/diagnóstico , Deficiencia de Vitamina B 12/tratamiento farmacológico , Complejo Vitamínico B/administración & dosificaciónAsunto(s)
Aneurisma/terapia , Síndrome de Behçet/complicaciones , Embolización Terapéutica/efectos adversos , Endoscopía , Cuerpos Extraños/etiología , Arteria Pulmonar , Adulto , Aneurisma/complicaciones , Aneurisma/diagnóstico por imagen , Fístula Bronquial/etiología , Broncoscopía , Embolización Terapéutica/instrumentación , Cuerpos Extraños/complicaciones , Cuerpos Extraños/diagnóstico , Cuerpos Extraños/terapia , Hemoptisis/etiología , Humanos , Masculino , Arteria Pulmonar/diagnóstico por imagen , Radiografía Torácica , Tomografía Computarizada por Rayos XAsunto(s)
Talón/diagnóstico por imagen , Tuberculosis Osteoarticular/diagnóstico por imagen , Tuberculosis Pulmonar/diagnóstico por imagen , Adulto , Antituberculosos/uso terapéutico , Edema/diagnóstico por imagen , Edema/microbiología , Talón/patología , Humanos , Masculino , Radiografía , Resultado del Tratamiento , Tuberculosis Osteoarticular/tratamiento farmacológico , Tuberculosis Osteoarticular/etiología , Tuberculosis Osteoarticular/patología , Tuberculosis Pulmonar/complicaciones , Tuberculosis Pulmonar/tratamiento farmacológico , Tuberculosis Pulmonar/patologíaRESUMEN
INTRODUCTION: HIV infection is associated with a wide variety of ophthalmic manifestations. The objective of this study was to identify the ocular complications of HIV/AIDS in Morocco. MATERIAL AND METHODS: A retrospective study conducted in the internal medicine department of the Rabat Teaching Hospital between 1998 and 2008. All HIV-positive patients were retained for the study. Each patient had an exhaustive ocular examination. RESULTS: Of 115 ophthalmologic examinations, 28 were abnormal. Twenty-seven patients had stage C HIV infection and one patient was in stage A. The ocular manifestations were: 21 cases of ocular HIV-related anomalies (microangiopathies), four cases of cytomegalovirus (CMV) retinitis, one case of toxoplasmosis chorioretinitis, one case of CMV retinitis associated with toxoplasmosis chorioretinitis, two cases of Cryptococcus neoformans infection, two cases of varicella-zoster virus (VZV) retinitis, and one case of conjunctival Kaposi sarcoma. The CD4 count average was of 86±91/mm(3). Twenty-six patients had a CD4 count lower than 200/mm(3). Progression was favorable in 85 % of the cases, with three cases of blindness: bilateral in a case of VZV retinitis and unilateral in two cases of CMV retinitis and toxoplasmosis chorioretinitis. CONCLUSION: CMV infection is the main ocular opportunistic infection in our series. However, Highly Active Antiretroviral Treatment (HAART) may be the cause for the decline in the prevalence of ocular diseases and visual impairment in HIV/AIDS.
Asunto(s)
Infecciones Oportunistas Relacionadas con el SIDA/diagnóstico , Oftalmopatías/diagnóstico , Trastornos de la Visión/diagnóstico , Infecciones Oportunistas Relacionadas con el SIDA/epidemiología , Adulto , Estudios Transversales , Oftalmopatías/epidemiología , Femenino , Encuestas Epidemiológicas , Humanos , Incidencia , Masculino , Persona de Mediana Edad , Marruecos , Estudios Retrospectivos , Trastornos de la Visión/epidemiología , Adulto JovenRESUMEN
OBJECTIVE: The hyperimmunoglobulinaemia D and periodic fever syndrome (HIDS) was originally defined by the presence of a high serum level of immunoglobulin D associated with recurrent fever. Since the discovery of the mevalonate kinase gene (MVK) gene encoding the mevalonate kinase enzyme, most patients with a clinical diagnostic of HIDS are now found to have a mevalonate kinase deficiency based on metabolic and genetic data. We aimed to asses the value of a high IgD serum level for the diagnosis of HIDS in a cohort of patients with a phenotype of recurrent fever, and to characterize patients with a high IgD serum level without mevalonate kinase mutation. METHODS: Main clinical and biological data of 50 patients who presented with clinical signs compatible with HIDS have been prospectively registered on a standard form. Clinical data have been analysed according the IgD serum level and the presence of MVK mutation. RESULTS: The metabolic and genetic data establishing the diagnosis of HIDS correlated in all cases. In this series of 50 patients, the sensitivity of a high IgD value for the diagnosis of HIDS is 0.79. In five patients with MVK mutation, IgD levels were found to be in the normal range. Likelihood ratios indicate that IgD measurement is not relevant for the diagnostic of HIDS. Most patients with a high serum IgD level and no MVK mutation have no definite diagnosis. CONCLUSION: The clinical relevance of the IgD measurement for the diagnosis of MKD in our population appears as poor, as reflected by likelihood ratios which are both close to 1.